[-] Show simple item record

dc.contributor.advisorLever, Susan Z., 1952-eng
dc.contributor.authorXu, Rong, 1977-eng
dc.date.issued2007eng
dc.date.submitted2007 Summereng
dc.descriptionThe entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file.eng
dc.descriptionTitle from title screen of research.pdf file (viewed on December 18, 2007)eng
dc.descriptionVita.eng
dc.descriptionIncludes bibliographical references.eng
dc.descriptionThesis (Ph. D.) University of Missouri-Columbia 2007.eng
dc.descriptionDissertations, Academic -- University of Missouri--Columbia -- Chemistry.eng
dc.description.abstractThe sigma receptor is a unique receptor family that has two subtypes: sigma1 and sigma2. Sigma1 receptors are involved in several physiological functions such as psychosis and depression. Sigma2 receptors are expressed in a variety of human tumors. Thus the selective sigma1 ligands have potential usage in central nervous system diseases, while sigma2 selective ligands can play an important role as biomarkers and therapeutic agents of tumor proliferation. Two well characterized compounds, SA4503 and conformationally flexible benzamide were chosen as our leads. Structural modifications were conducted in order to study the effect of structural elements on sigma binding properties; the possibility of new ligands as potential SPECT imaging agents was also explored. The result showed most of the SA4503 analogs had moderate affinity and no selectivity between sigma1 and sigma2 receptor subtype. All of these analogs had increased binding affinity for sigma2 subtype than their lead compound SA4503. The modifications made by replacing the left phenylpropyl group of SA4503 with an N-iodoallyl group yielded a sigma1 selective ligand (1h-7, E-IA-DM-PE-PIPZ) that had appropriate lipophilicity for penetrating the blood brain barrier in the CNS. The in vivo studies using radioiodinated 1h-7 showed that it had high specific binding to the sigma1 receptor in the mouse brain and thus it had great potential as SPECT agent for brain imaging. The modifications on the benzamide series of compounds by rigid dioxy rings showed similar trend in binding affinities as observed in the similar modification made on theSA4503 phenolic side chain, the most rigid methylenedioxy analog had the highest affinity and the least rigid propylenedioxy had the lowest affinity for sigma1 subtype. Sigma2 affinity was not affected significantly by the size of the dioxy ring. The modification of the strained tetrahydroisoquinoline ring with a freely rotating amine chain maintained the sigma1 affinity unchanged, while decreasing the sigma2 binding affinity dramatically. Thus a rigid tetrahydroisoquinoline is an important structural element for selective sigma2 binding in the benzamides series compounds.eng
dc.identifier.merlin.b61533245eng
dc.identifier.oclc184845644eng
dc.identifier.otherXuR-072407-D7771eng
dc.identifier.urihttp://hdl.handle.net/10355/4742eng
dc.languageEnglisheng
dc.publisherUniversity of Missouri--Columbiaeng
dc.relation.ispartofcollectionUniversity of Missouri--Columbia. Graduate School. Theses and Dissertationseng
dc.subject.lcshSigma receptorseng
dc.subject.lcshCentral nervous system -- Diseaseseng
dc.subject.lcshBiochemical markerseng
dc.subject.lcshAnalytical biochemistryeng
dc.subject.lcshLigand binding (Biochemistry)eng
dc.subject.lcshProtein bindingeng
dc.titleThe effects of structural modifications on sigma receptor bindingeng
dc.typeThesiseng
thesis.degree.disciplineChemistry (MU)eng
thesis.degree.grantorUniversity of Missouri--Columbiaeng
thesis.degree.levelDoctoraleng
thesis.degree.namePh. D.eng


Files in this item

[PDF]
[PDF]
[PDF]

This item appears in the following Collection(s)

[-] Show simple item record